Phenylketonurias

Search with Google Search with Bing
Information
Disease name
Phenylketonurias
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04898829 Active, not recruiting N/A Evaluation of PKU Explore France May 18, 2022 May 31, 2025
NCT05174559 Active, not recruiting N/A Additional Dietary Large Neutral Amino Acids (LNAA) for Improved Symptoms in Adult Classical Phenylktonuria (PKU) September 1, 2023 July 31, 2024
NCT06332105 Active, not recruiting N/A Evaluation of Low Phenylalanine Formulas January 30, 2023 April 2025
NCT05971563 Active, not recruiting N/A Amino Acid Kinetics of GMP-AA in Healthy Human Volunteers October 18, 2022 August 31, 2023
NCT02445521 Completed Testing of Four Home Phenylalanine Monitoring Prototype Devices May 2015 May 2015
NCT03167697 Completed N/A Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia May 1, 2017 December 17, 2018
NCT03419819 Completed N/A Evaluation of PKU Sphere May 1, 2018 May 21, 2019
NCT03771391 Completed N/A A 16 Week Study Evaluating the Introduction of a GMP Based Protein Substitute in Participants With PKU December 6, 2018 July 31, 2023
NCT03777826 Completed N/A Effects of Synergy on Nutrient Intake and Acceptability in Phenylketonuria (PKU) June 26, 2019 May 27, 2021
NCT03792451 Completed Nutrition Status of Adults Treated With Pegvaliase January 17, 2019 December 31, 2020
NCT03820804 Completed Nutritional Status in Phenylketonuria January 7, 2019 September 10, 2019
NCT03856203 Completed Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase March 8, 2019 October 20, 2023
NCT04076176 Completed N/A The Effects of CGMP in Children and Adults With PKU April 26, 2019 January 31, 2023
NCT00225615 Completed Phase 3 A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels November 2005 June 2006
NCT05096988 Completed N/A Evaluation of PKU Sphere Liquid November 23, 2021 February 28, 2023
NCT00272792 Completed Phase 3 Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet February 2006 November 2006
NCT01209819 Completed Bone Mineral Density in Adults With Hyperphenylalaninemia September 2010 October 2012
NCT04368624 Completed PKU Skin Stripping October 12, 2015 April 2021
NCT04375592 Completed Acceptability and Tolerance of a Ready-to-use Protein Substitute in Tablet Form for the Dietary Management of Phenylketonuria February 1, 2021 May 10, 2021
NCT00104260 Completed Phase 2 Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria December 2004 November 2005
NCT04452513 Completed A Prospective Clinical Study of Phenylketonuria (PKU) October 11, 2019 June 2, 2022
NCT04679467 Completed N/A Evaluation of PKU Sphere in Italy January 15, 2020 July 31, 2022
NCT05249218 Completed N/A Impact of Fruit and Vegetables in PKU July 20, 2019 June 30, 2021
NCT04943393 Completed Remote Neurocognitive and Psychological Assessment in PKU November 24, 2020 October 2, 2021
NCT04248062 Completed Patient and Observer Reported Outcome Measurements in Inborn Errors of Metabolism August 1, 2019 October 16, 2020
NCT00104247 Completed Phase 3 Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels March 2005 February 2006
NCT05497050 Completed N/A The Effect of Nursing Empowerment Program November 24, 2021 June 22, 2023
NCT04309331 Completed N/A Market Research - Acceptability Trial for a New PKU Amino Acid Based Protein Substitute July 1, 2018 September 19, 2018
NCT04318509 Completed N/A Market Research - Acceptability Study for a New PKU Protein Substitute February 4, 2019 May 19, 2019
NCT03655223 Enrolling by invitation Early Check: Expanded Screening in Newborns October 15, 2018 December 31, 2025
NCT05356377 Enrolling by invitation Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU May 25, 2022 April 30, 2024
NCT06332807 Not yet recruiting Phase 1/Phase 2 AAV Gene Therapy Clinical Study in Adult Classic PKU November 22, 2024 December 30, 2030
NCT04433728 Not yet recruiting Life With Phenylketonuria. Adult Neurological Outcome of PCU Screened Patients From 1971 to 2002. September 2022 September 2024
NCT04272736 Not yet recruiting N/A PKU Low Calorie Drink Study December 1, 2023 December 31, 2023
NCT06337864 Not yet recruiting N/A Evaluating the Efficacy and Safety of Large Neutral Amino Acids in the Treatment of Classical Phenylketonuria May 2024 December 2027
NCT04969809 Not yet recruiting N/A Comparison of Atherogenic Risk Factors and Efficacy of Nutritional Treatment Among Adult Phenylketonuria Patients September 1, 2021 September 1, 2026
NCT05827536 Recruiting N/A Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU. October 30, 2023 July 31, 2024
NCT04404530 Recruiting Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU) October 8, 2019 November 2027
NCT05051657 Recruiting N/A Evaluation of the Express Plus Range June 14, 2021 April 30, 2025
NCT05128149 Recruiting Metabolic Control and Patient Well-being in Phenylketonuria: do Guidelines Make a Difference? November 15, 2021 December 31, 2024
NCT05487378 Recruiting N/A Evaluation of Phe Fluctuation in PKU Pts Treated With PKU GOLIKE Versus Standard Amino Acid Protein Substitute. June 30, 2023 June 2024
NCT05998109 Recruiting PheCheck Feasibility Study September 5, 2023 March 15, 2024
NCT06061614 Recruiting Early Phase 1 Safety and Efficacy Study of NGGT002 in PKU Adult Subjects March 30, 2023 December 30, 2028
NCT04768348 Terminated Natural History Clinical Study in Adult PKU April 20, 2021 August 1, 2023
NCT04110496 Terminated Phase 1 Safety and Tolerability of RTX-134 in Adults With Phenylketonuria January 29, 2020 December 1, 2022
NCT04210206 Terminated N/A Short-term Effects of Good Metabolic Control on Cognitive Function, Wellbeing, and Metabolic Parameters in Adult Patients With Phenylketonuria December 1, 2019 August 31, 2023
NCT03952156 Terminated Phase 1/Phase 2 Gene Therapy Clinical Study in Adult PKU June 10, 2019 August 1, 2023
NCT05222178 Terminated Phase 1 Safety and Efficacy of HMI-103 in Participants With Classical PKU Due to PAH Deficiency June 3, 2022 September 14, 2023
NCT05229549 Terminated N/A Study to Evaluate the Effect on Nitrogen Retention of Two Different Posology Schemes of PKU GOLIKE PLUS 3-16 and Free AAs in Patients With Phenylketonuria May 6, 2022 February 7, 2023
NCT04251494 Unknown status A Study Into the Future Cardiovascular Disease (CVD) Risk of Phenylketonuria (PKU) Patients on a Low Phenylalanine Treatment Diet (LPD). February 23, 2019 April 22, 2021
NCT04302194 Unknown status Early Dietary Treated Patients With Phenylketonuria Can Achieve Normal Growth and Mental Development. May 1, 2020 October 2021
NCT04256655 Withdrawn Phase 1 Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of CDX 6114 in PKU Patients December 1, 2020 December 30, 2021
NCT03333720 Withdrawn N/A Compliance, Tolerance and Acceptability of a Tablet Protein Substitute for the Dietary Management of Phenylketonuria July 15, 2019 December 31, 2019
MeSH unique ID (MeSH (Medical Subject Headings))
D010661